Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Structural basis of multimer-mediated mayhem.

Kajal V Sitwala1, Jay L Hess

  • 1Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA.

Cancer Cell
|April 18, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

HLH and TET2 Mutation Presenting after First Cycle of CLL Treatment.

Clinical medicine & research·2023
Same author

Medical School Without Walls: 50 Years of Regional Campuses at Indiana University School of Medicine.

Academic medicine : journal of the Association of American Medical Colleges·2022
Same author

Erratum for Caslini et al., "MLL Associates with Telomeres and Regulates Telomeric Repeat-Containing RNA Transcription".

Molecular and cellular biology·2021
Same author

HoxA9 binds and represses the Cebpa +8 kb enhancer.

PloS one·2019
Same author

HOXA9 Reprograms the Enhancer Landscape to Promote Leukemogenesis.

Cancer cell·2018
Same author

A new target for differentiation therapy in AML.

Cell research·2016
Same journal

Circadian Homeostasis of Liver Metabolism Suppresses Hepatocarcinogenesis.

Cancer cell·2026
Same journal

Vascular RhoJ Is an Effective and Selective Target for Tumor Angiogenesis and Vascular Disruption.

Cancer cell·2026
Same journal

Intratumoral B cells under stress.

Cancer cell·2026
Same journal

Chronic stress unleashes an intratumor phage-fibroblast-B cell circuit to promote tumor growth.

Cancer cell·2026
Same journal

Molecular phenotypes and spatial archetypes: A new framework for cancer-associated fibroblasts.

Cancer cell·2026
Same journal

OpenIO: An open framework for AI-native immunotherapy.

Cancer cell·2026
See all related articles

AML1-ETO oligomerization is crucial for leukemia development. Researchers discovered the ETO NHR2 domain forms a tetramer, essential for cancer cell self-renewal and gene regulation.

Area of Science:

  • Molecular biology
  • Cancer research
  • Structural biology

Background:

  • Oligomerization of AML1-ETO is implicated in leukemogenesis via poorly understood mechanisms.
  • The ETO corepressor complex plays a role in gene regulation and cellular processes.

Purpose of the Study:

  • To elucidate the structural basis of AML1-ETO oligomerization.
  • To determine the functional significance of ETO NHR2 domain self-association in leukemogenesis.

Main Methods:

  • X-ray crystallography to determine the structure of the ETO NHR2 domain.
  • Functional assays to assess the impact of oligomerization on cellular processes like maturation arrest and self-renewal.
  • Analysis of gene expression changes in cells with disrupted ETO self-association.

Related Experiment Videos

Main Results:

  • The crystal structure reveals the ETO NHR2 domain forms a tetramer.
  • Tetramer formation is critical for AML1-ETO's role in maturation arrest and self-renewal.
  • Disruption of oligomerization alters gene expression patterns.
  • Loss of self-association specifically impairs interactions with the ETO corepressor family.

Conclusions:

  • ETO NHR2 domain tetramerization is a key mechanism in AML1-ETO-driven leukemogenesis.
  • Oligomerization regulates AML1-ETO function by mediating interactions with specific corepressors.
  • Targeting ETO-corepressor interactions presents a potential therapeutic strategy for leukemia.